| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Jaguar Health (NASDAQ:JAGX) is gearing up to announce its quarterly earnings on Thursday, 2025-08-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Jaguar Health will report an earnings per share (EPS) of $-7.13.
Jaguar Health bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
During the last quarter, the company reported an EPS missed by $5.88, leading to a 6.91% increase in the share price on the subsequent day.
Here's a look at Jaguar Health's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -10.82 | -18.50 | -59.25 | -27.75 |
| EPS Actual | -16.70 | -8.44 | -26.25 | -101 |
| Price Change % | 7.000000000000001% | 0.0% | 5.0% | 0.0% |
Shares of Jaguar Health were trading at $2.35 as of August 12. Over the last 52-week period, shares are down 91.93%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Jaguar Health visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: JAGX
